141 related articles for article (PubMed ID: 6614895)
21. beta-Lactam antibiotic modulation of murine neutrophil cytokinesis.
Kenny MT; Balistreri FJ; Torney HL
Immunopharmacol Immunotoxicol; 1992; 14(4):797-811. PubMed ID: 1294624
[TBL] [Abstract][Full Text] [Related]
22. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Scribner RK; Marks MI; Weber AH; Tarpay MM; Welch DF
Antimicrob Agents Chemother; 1982 Jun; 21(6):939-43. PubMed ID: 6810757
[TBL] [Abstract][Full Text] [Related]
23. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Mastella G; Agostini M; Barlocco G; Bonomi U; Borgo G; Bozzino L; Cabrini G; Cappelletti LM; Castellani L; Conforti M
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():297-311. PubMed ID: 6311788
[TBL] [Abstract][Full Text] [Related]
24. Effects of non-steroidal anti-inflammatory drugs on human leucocytes.
Wildfeuer A
Z Rheumatol; 1983; 42(1):16-20. PubMed ID: 6845886
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
Jayappa HG; Loken KI
Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
[TBL] [Abstract][Full Text] [Related]
26. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
[TBL] [Abstract][Full Text] [Related]
27. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
Labro MT; Babin-Chevaye C; Hakim J
J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
Thompson RL; Fisher KA; Wenzel RP
Antimicrob Agents Chemother; 1982 Feb; 21(2):341-3. PubMed ID: 6951505
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives.
Jacobs MR; Kelly F; Speck WT
Antimicrob Agents Chemother; 1982 Nov; 22(5):897-900. PubMed ID: 6758692
[TBL] [Abstract][Full Text] [Related]
30. Dimethyl sulfoxide inhibits phagocyte influx into infected pleural spaces and phagocyte locomotion in vitro.
Antony VB; Sahn SA; Repine JE
Inflammation; 1983 Dec; 7(4):377-85. PubMed ID: 6654475
[TBL] [Abstract][Full Text] [Related]
31. [Changes in the functional activity of human neutrophils under the action of recombinant interleukin-2].
Potapnev MP; Marinich DV; Pechkovskiĭ DV; Bortkevich LG; Maslovskaia AM
Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):80-4. PubMed ID: 8017134
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of macrolides on human phagocytic functions.
Fietta A; Bersani C; Santagada T; Bertoletti R; Gialdroni Grassi G
Chemioterapia; 1987 Feb; 6(1):52-6. PubMed ID: 3829136
[TBL] [Abstract][Full Text] [Related]
33. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Verbist L
Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
[TBL] [Abstract][Full Text] [Related]
34. The effect of antibiotics on the function of the phagocytic system.
Miler I; Borte M; Hejzlar M; Braun W
Padiatr Grenzgeb; 1990; 29(5):377-85. PubMed ID: 2234979
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of new beta-lactam antibiotics and other antimicrobial drugs against anaerobic isolates from obstetric and gynecological infections.
Ohm-Smith MJ; Hadley WK; Sweet RL
Antimicrob Agents Chemother; 1982 Oct; 22(4):711-4. PubMed ID: 7181484
[TBL] [Abstract][Full Text] [Related]
36. Influence of LY146032 on human polymorphonuclear leucocytes in vitro.
Van der Auwera P; Petrikkos G; Matsumoto T; Husson M
J Antimicrob Chemother; 1988 Jan; 21(1):57-63. PubMed ID: 2833489
[TBL] [Abstract][Full Text] [Related]
37. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone].
Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C
Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis.
Tweardy DJ; Jacobs MR; Speck WT
J Antimicrob Chemother; 1983 Aug; 12(2):133-9. PubMed ID: 6555189
[TBL] [Abstract][Full Text] [Related]
39. Comparative antipseudomonal activity of some newer beta-lactam agents.
Greenwood D; Eley A
Antimicrob Agents Chemother; 1982 Feb; 21(2):204-9. PubMed ID: 6803664
[TBL] [Abstract][Full Text] [Related]
40. Bactericidal activity of cefoperazone in comparison with other beta-lactam antibiotics and gentamicin.
Welch DF; Matsen JM
Clin Ther; 1980; 3(Spec Issue):127-9. PubMed ID: 6446385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
